270 related articles for article (PubMed ID: 21076445)
1. Tenofovir-induced kidney disease: an acquired renal tubular mitochondriopathy.
Perazella MA
Kidney Int; 2010 Dec; 78(11):1060-3. PubMed ID: 21076445
[TBL] [Abstract][Full Text] [Related]
2. Tenofovir nephrotoxicity: acute tubular necrosis with distinctive clinical, pathological, and mitochondrial abnormalities.
Herlitz LC; Mohan S; Stokes MB; Radhakrishnan J; D'Agati VD; Markowitz GS
Kidney Int; 2010 Dec; 78(11):1171-7. PubMed ID: 20811330
[TBL] [Abstract][Full Text] [Related]
3. Early markers of tubular dysfunction in antiretroviral-experienced HIV-infected patients treated with tenofovir versus abacavir.
Maggi P; Montinaro V; Bellacosa C; Pietanza S; Volpe A; Graziano G; Strippoli GF; Angarano G
AIDS Patient Care STDS; 2012 Jan; 26(1):5-11. PubMed ID: 22136504
[TBL] [Abstract][Full Text] [Related]
4. Tenofovir-associated renal and bone toxicity.
Woodward CL; Hall AM; Williams IG; Madge S; Copas A; Nair D; Edwards SG; Johnson MA; Connolly JO
HIV Med; 2009 Sep; 10(8):482-7. PubMed ID: 19459988
[TBL] [Abstract][Full Text] [Related]
5. Proximal renal tubular dysfunction related to antiretroviral therapy among HIV-infected patients in an HIV clinic in Mexico.
Andrade-Fuentes K; Mata-Marín JA; López-De León JI; Manjarrez-Téllez B; Ramírez JL; Gaytan-Martínez J
AIDS Patient Care STDS; 2015 Apr; 29(4):181-5. PubMed ID: 25101526
[TBL] [Abstract][Full Text] [Related]
6. Tenofovir-associated proteinuria.
Kelly MD; Gibson A; Bartlett H; Rowling D; Patten J
AIDS; 2013 Jan; 27(3):479-81. PubMed ID: 22874515
[TBL] [Abstract][Full Text] [Related]
7. Progressive renal tubular dysfunction associated with long-term use of tenofovir DF.
Kinai E; Hanabusa H
AIDS Res Hum Retroviruses; 2009 Apr; 25(4):387-94. PubMed ID: 19361280
[TBL] [Abstract][Full Text] [Related]
8. Tenofovir renal toxicity targets mitochondria of renal proximal tubules.
Kohler JJ; Hosseini SH; Hoying-Brandt A; Green E; Johnson DM; Russ R; Tran D; Raper CM; Santoianni R; Lewis W
Lab Invest; 2009 May; 89(5):513-9. PubMed ID: 19274046
[TBL] [Abstract][Full Text] [Related]
9. Proximal tubular kidney damage and tenofovir: a role for mitochondrial toxicity?
Saumoy M; Vidal F; Peraire J; Sauleda S; Vea AM; Viladés C; Ribera E; Richart C
AIDS; 2004 Aug; 18(12):1741-2. PubMed ID: 15280790
[No Abstract] [Full Text] [Related]
10. Adefovir nephrotoxicity: possible role of mitochondrial DNA depletion.
Tanji N; Tanji K; Kambham N; Markowitz GS; Bell A; D'agati VD
Hum Pathol; 2001 Jul; 32(7):734-40. PubMed ID: 11486172
[TBL] [Abstract][Full Text] [Related]
11. Delayed onset renal failure in a patient on tenofovir based antiretroviral regimen.
Krishna MM; Subbalaxmi MV; Uppin M; Radhika S
Indian J Pharmacol; 2014; 46(2):230-1. PubMed ID: 24741201
[TBL] [Abstract][Full Text] [Related]
12. Changes in the renal function after tenofovir-containing antiretroviral therapy initiation in a Senegalese cohort (ANRS 1215).
De Beaudrap P; Diallo MB; Landman R; Guèye NF; Ndiaye I; Diouf A; Kane CT; Etard JF; Girard PM; Sow PS; Delaporte E;
AIDS Res Hum Retroviruses; 2010 Nov; 26(11):1221-7. PubMed ID: 20854202
[TBL] [Abstract][Full Text] [Related]
13. ASN clinical pathological conference. Tenofovir-related ATN (severe).
Atta MG; Stokes MB
Clin J Am Soc Nephrol; 2013 May; 8(5):882-90. PubMed ID: 23371959
[No Abstract] [Full Text] [Related]
14. Tenofovir-induced osteomalacia.
Wanner DP; Tyndall A; Walker UA
Clin Exp Rheumatol; 2009; 27(6):1001-3. PubMed ID: 20149322
[TBL] [Abstract][Full Text] [Related]
15. Tubulopathy consecutive to tenofovir-containing antiretroviral therapy in two patients infected with human immunodeficiency virus-1.
Breton G; Alexandre M; Duval X; Prie D; Peytavin G; Leport C; Vildei JL
Scand J Infect Dis; 2004; 36(6-7):527-8. PubMed ID: 15307594
[TBL] [Abstract][Full Text] [Related]
16. A tailored dose of tenofovir could reduce its impact on bone mass in HIV Type 1-infected children and adolescents: a report from 5 years of clinical experience.
Rosso R; Parodi A; Torrisi C; De Terlizzi F; Viscoli C; Vignolo M
AIDS Res Hum Retroviruses; 2010 Dec; 26(12):1265-6. PubMed ID: 20874420
[No Abstract] [Full Text] [Related]
17. Proximal tubular renal dysfunction or damage in HIV-infected patients.
Del Palacio M; Romero S; Casado JL
AIDS Rev; 2012; 14(3):179-87. PubMed ID: 22833061
[TBL] [Abstract][Full Text] [Related]
18. Acute tubular necrosis in a patient receiving tenofovir.
Lee JC; Marosok RD
AIDS; 2003 Nov; 17(17):2543-4. PubMed ID: 14600530
[No Abstract] [Full Text] [Related]
19. The rate of recovery in renal function when patients with HIV infection discontinue treatment with tenofovir.
Young J; Wang Q; Fux CA; Bernasconi E; Furrer H; Vernazza P; Calmy A; Cavassini M; Weber R; Battegay M; Bucher HC;
HIV Med; 2014 Sep; 15(8):505-10. PubMed ID: 24641488
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial dysfunction and electron transport chain complex defect in a rat model of tenofovir disoproxil fumarate nephrotoxicity.
Ramamoorthy H; Abraham P; Isaac B
J Biochem Mol Toxicol; 2014 Jun; 28(6):246-55. PubMed ID: 24615786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
